Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
AI Summary
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Discussion
Sign in to join the discussion.
Loading comments…